Literature DB >> 29995629

Detection capability of quantitative faecal immunochemical tests for haemoglobin (FIT) and reporting of low faecal haemoglobin concentrations.

Callum G Fraser1, Sally C Benton2.   

Abstract

Faecal immunochemical tests for haemoglobin (FIT) are widely used in asymptomatic population screening for colorectal (bowel) cancer. FIT are also used to assist with the assessment of patients presenting with lower abdominal symptoms. Quantitative FIT allow the generation of numerical estimates of faecal haemoglobin (f-Hb) concentrations. There is now great interest in "low" f-Hb concentrations in these clinical settings: in consequence, knowledge of the detection capability is very important for f-Hb concentration examinations. There are a number of current problems associated with the reporting of low f-Hb concentrations and wide misunderstanding of the metrological aspects of examinations of f-Hb at low concentrations. These would be solved if the detectability characteristics of f-Hb concentration examinations, namely, the limit of blank (LoB), limit of detection (LoD) and limit of quantitation (LoQ), were generated, validated and used in reporting systems exactly as recommended in the EP17-A2 guideline of the Clinical Laboratory Standards Institute. LoB and LoD are statistical concepts, but the LoQ depends on definition of analytical performance specifications (APS). In this Opinion Paper proposals for interim APS are made, based on the current state of the art achieved with examinations of faecal samples. It is proposed that LoQ is determined at an examination imprecision of CV≤10% using faecal samples naturally positive for Hb rather than faeces spiked with haemolysate. Detailed proposals for reporting f-Hb data at low concentrations are also made.

Entities:  

Keywords:  detection capability; faecal haemoglobin; faecal immunochemical test; limit of blank; limit of detection; limit of quantitation

Year:  2019        PMID: 29995629     DOI: 10.1515/cclm-2018-0464

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

1.  The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients.

Authors:  N D'Souza; G Hicks; S C Benton; M Abulafi
Journal:  Ann R Coll Surg Engl       Date:  2019-11-07       Impact factor: 1.891

2.  Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.

Authors:  Craig Mowat; Jayne Digby; Judith A Strachan; Rebecca K McCann; Francis A Carey; Callum G Fraser; Robert Jc Steele
Journal:  Ann Clin Biochem       Date:  2021-01-21       Impact factor: 2.057

3.  The use of faecal haemoglobin in deciding which patients presenting to primary care require further investigation (and how quickly) - the FIT approach.

Authors:  Judith A Strachan; Craig Mowat
Journal:  EJIFCC       Date:  2021-02-28

4.  Evaluation of the Sentinel-FOB gold faecal immunochemical test for the presence of haemoglobin using the automated Roche Cobas 8000 system.

Authors:  Lutz Schwettmann; Astrid Lied; Ragnar Eriksen
Journal:  Pract Lab Med       Date:  2022-01-15

5.  Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme.

Authors:  Gavin Rc Clark; Jayne Digby; Callum G Fraser; Judith A Strachan; Robert Jc Steele
Journal:  J Med Screen       Date:  2021-11-22       Impact factor: 2.136

6.  Faecal haemoglobin concentration in adenoma, before and after polypectomy, approaches the ideal tumour marker.

Authors:  Craig Mowat; Jayne Digby; Shirley Cleary; Lynne Gray; Pooja Datt; David R Goudie; Robert Jc Steele; Judith A Strachan; Adam Humphries; Callum G Fraser
Journal:  Ann Clin Biochem       Date:  2022-03-02       Impact factor: 2.587

7.  Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.

Authors:  Jayne Digby; Shirley Cleary; Lynne Gray; Pooja Datt; David R Goudie; Robert J C Steele; Judith A Strachan; Adam Humphries; Callum G Fraser; Craig Mowat
Journal:  United European Gastroenterol J       Date:  2020-03-16       Impact factor: 4.623

8.  Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.

Authors:  Jayne Digby; Judith A Strachan; Craig Mowat; Robert J C Steele; Callum G Fraser
Journal:  BMC Gastroenterol       Date:  2019-12-11       Impact factor: 3.067

9.  Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.

Authors:  Nigel D'Souza; Theo Georgiou Delisle; Michelle Chen; Sally Benton; Muti Abulafi
Journal:  Gut       Date:  2020-10-21       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.